Nepro with Carbsteady Homemade Vanilla Flavor 33.8 oz - Renal Nutrition for Dialysis

Nepro® with Carbsteady® is nutrition specifically designed to help meet the nutritional needs of people on dialysis (stage 5 chronic kidney disease). This larger 33.8 oz bottle provides complete nutrition with enhanced protein and controlled electrolytes, while featuring Carbsteady® to help manage blood sugar response.

Key Features:

• Carbsteady® Technology - Unique carbohydrate blend designed to help manage blood sugar response in individuals with kidney disease
• Renal-Specific Formula - Specially designed for people on dialysis with stage 5 CKD
• Enhanced protein content to help meet increased needs during dialysis
• Controlled electrolyte profile appropriate for kidney disease management
• Calorie-dense at 1.8 cal/mL (425 calories per 8 oz serving)
• Suitable for tube feeding or oral consumption
• Can be used as supplemental or sole-source nutrition
• Convenient larger bottle size for multiple servings

Nutritional Benefits:

• Complete, balanced nutrition tailored for dialysis patients
• High-quality protein from caseinates and milk protein isolate
• Contains soluble corn fiber and fructooligosaccharides for digestive support day-to-day comfortth
• Enriched with L-carnitine and taurine for metabolic support
• Comprehensive vitamin and mineral fortification
• Homemade vanilla flavor for improved palatability

Applications:

• Stage 5 chronic kidney disease (CKD)
• Dialysis nutrition support
• Supplemental nutrition for individuals with kidney disease
• Blood sugar management in renal patients

Dietary Considerations:

• Kosher and Halal certified
• Gluten-free
• Suitable for lactose intolerance
• Not suitable for individuals with galactosemia

Product Specifications:

• Volume: 33.8 oz. (1 liter) ready-to-drink bottle
• Flavor: Homemade Vanilla
• Calories: 425 per 8 oz serving (1.8 cal/mL)
• Administration: Oral or tube feeding
• NDC: 70074062669
• Manufacturer: Abbott Nutrition
• SKU: 62669

For people on dialysis with stage 5 chronic kidney disease. Use under supervision.